Amsali, Ziyan .

HRN: 28-13-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/20/2025
CEFTAZIDIME 1GM (VIAL)
11/20/2025
11/26/2025
IV
500mg
Q8
PCAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines